Brainstorm Cell Therapeutics Stock Analysis

BCLI Stock  USD 1.74  0.12  7.41%   
Brainstorm Cell Therapeutics is undervalued with Real Value of 2.6 and Target Price of 5.25. The main objective of Brainstorm Cell stock analysis is to determine its intrinsic value, which is an estimate of what Brainstorm Cell Therapeutics is worth, separate from its market price. There are two main types of Brainstorm Cell's stock analysis: fundamental analysis and technical analysis.
The Brainstorm Cell stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Brainstorm Cell's ongoing operational relationships across important fundamental and technical indicators.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Brainstorm Cell Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

Brainstorm Stock Analysis Notes

About 14.0% of the company shares are held by institutions such as insurance companies. The company recorded a loss per share of 3.45. Brainstorm Cell Ther had not issued any dividends in recent years. The entity had 1:15 split on the 1st of October 2024. Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. Brainstorm Cell Therapeutics Inc. was incorporated in 2000 and is headquartered in New York, New York. Brainstorm Cell operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 43 people. For more info on Brainstorm Cell Therapeutics please contact Chaim Lebovits at 201 488 0460 or go to https://www.brainstorm-cell.com.

Brainstorm Cell Ther Investment Alerts

Brainstorm Cell Ther generated a negative expected return over the last 90 days
Brainstorm Cell Ther has high historical volatility and very poor performance
Brainstorm Cell Ther may become a speculative penny stock
Brainstorm Cell Ther has a very high chance of going through financial distress in the upcoming years
Net Loss for the year was (17.19 M) with profit before overhead, payroll, taxes, and interest of 0.
Brainstorm Cell Therapeutics currently holds about 12.24 M in cash with (20.46 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.34.
Brainstorm Cell Ther has a frail financial position based on the latest SEC disclosures
Latest headline from MacroaxisInsider: Acquisition by Arbel Irit of 25333 shares of Brainstorm Cell at 0.75 subject to Rule 16b-3

Brainstorm Cell Ther Upcoming and Recent Events

Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Brainstorm Cell previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
4th of April 2024
Upcoming Quarterly Report
View
20th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
4th of April 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Brainstorm Largest EPS Surprises

Earnings surprises can significantly impact Brainstorm Cell's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2023-05-15
2023-03-31-0.16-0.140.0212 
2022-05-16
2022-03-31-0.13-0.15-0.0215 
2016-11-14
2016-09-30-0.11-0.090.0218 
View All Earnings Estimates

Brainstorm Stock Institutional Investors

Shares
Two Sigma Securities, Llc2024-06-30
102 K
Tower Research Capital Llc2024-06-30
86.6 K
Virtu Financial Llc2024-06-30
49.6 K
Group One Trading, Lp2024-06-30
46.8 K
Morgan Stanley - Brokerage Accounts2024-06-30
37 K
Wells Fargo & Co2024-06-30
28.8 K
Creative Planning Inc2024-06-30
20.9 K
Janney Montgomery Scott Llc2024-06-30
20.5 K
Jane Street Group Llc2024-06-30
19.8 K
Armistice Capital, Llc2024-06-30
7.9 M
Vanguard Group Inc2024-06-30
1.5 M
Note, although Brainstorm Cell's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Brainstorm Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 9.92 M.

Brainstorm Profitablity

Last ReportedProjected for Next Year
Return On Tangible Assets(4.09)(4.29)
Return On Capital Employed 5.97  6.27 
Return On Assets(4.09)(4.29)
Return On Equity 3.54  3.72 

Management Efficiency

Brainstorm Cell Ther has return on total asset (ROA) of (1.782) % which means that it has lost $1.782 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (11.219) %, meaning that it created substantial loss on money invested by shareholders. Brainstorm Cell's management efficiency ratios could be used to measure how well Brainstorm Cell manages its routine affairs as well as how well it operates its assets and liabilities. As of now, Brainstorm Cell's Return On Capital Employed is increasing as compared to previous years. The Brainstorm Cell's current Return On Equity is estimated to increase to 3.72, while Return On Tangible Assets are projected to decrease to (4.29). The current Total Assets is estimated to decrease to about 4 M. The current Non Current Assets Total is estimated to decrease to about 1.6 M
Last ReportedProjected for Next Year
Book Value Per Share(0.11)(0.11)
Tangible Book Value Per Share(0.11)(0.11)
Enterprise Value Over EBITDA(10.37)(10.89)
Price Book Value Ratio(36.27)(38.09)
Enterprise Value Multiple(10.37)(10.89)
Price Fair Value(36.27)(38.09)
Enterprise Value158 M150.1 M
The decision-making processes within Brainstorm Cell are key to its success in a competitive market. By evaluating these processes, we assess the stock's potential for future gains.
Beta
0.391
Return On Assets
(1.78)
Return On Equity
(11.22)

Technical Drivers

As of the 30th of November, Brainstorm Cell shows the risk adjusted performance of (0.16), and Mean Deviation of 4.45. Brainstorm Cell Ther technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.

Brainstorm Cell Ther Price Movement Analysis

Execute Study
The output start index for this execution was nine with a total number of output elements of fifty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Brainstorm Cell middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Brainstorm Cell Ther. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Brainstorm Cell Ther Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Brainstorm Cell insiders, such as employees or executives, is commonly permitted as long as it does not rely on Brainstorm Cell's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Brainstorm Cell insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Brainstorm Cell Outstanding Bonds

Brainstorm Cell issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Brainstorm Cell Ther uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Brainstorm bonds can be classified according to their maturity, which is the date when Brainstorm Cell Therapeutics has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Brainstorm Cell Predictive Daily Indicators

Brainstorm Cell intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Brainstorm Cell stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Brainstorm Cell Forecast Models

Brainstorm Cell's time-series forecasting models are one of many Brainstorm Cell's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Brainstorm Cell's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Brainstorm Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Brainstorm Cell prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Brainstorm shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Brainstorm Cell. By using and applying Brainstorm Stock analysis, traders can create a robust methodology for identifying Brainstorm entry and exit points for their positions.
Last ReportedProjected for Next Year
Pretax Profit Margin 57.18  60.04 
Operating Profit Margin 56.56  59.39 
Net Profit Margin 57.80  60.69 
Gross Profit Margin 0.16  0.21 

Current Brainstorm Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Brainstorm analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Brainstorm analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
5.25Buy1Odds
Brainstorm Cell Therapeutics current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Brainstorm analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Brainstorm stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Brainstorm Cell Ther, talking to its executives and customers, or listening to Brainstorm conference calls.
Brainstorm Analyst Advice Details

Brainstorm Stock Analysis Indicators

Brainstorm Cell Therapeutics stock analysis indicators help investors evaluate how Brainstorm Cell stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Brainstorm Cell shares will generate the highest return on investment. By understating and applying Brainstorm Cell stock analysis, traders can identify Brainstorm Cell position entry and exit signals to maximize returns.
Begin Period Cash Flow772 K
Common Stock Shares Outstanding43.1 M
Total Stockholder Equity-4.9 M
Property Plant And Equipment Net2.1 M
Cash And Short Term Investments1.3 M
Cash1.3 M
Accounts PayableM
Net Debt-628 K
50 Day M A2.1054
Total Current Liabilities7.8 M
Other Operating Expenses21.4 M
Non Current Assets Total2.3 M
Non Currrent Assets Other207 K
Stock Based Compensation1490.00

Complementary Tools for Brainstorm Stock analysis

When running Brainstorm Cell's price analysis, check to measure Brainstorm Cell's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Brainstorm Cell is operating at the current time. Most of Brainstorm Cell's value examination focuses on studying past and present price action to predict the probability of Brainstorm Cell's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Brainstorm Cell's price. Additionally, you may evaluate how the addition of Brainstorm Cell to your portfolios can decrease your overall portfolio volatility.
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Transaction History
View history of all your transactions and understand their impact on performance
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals